May 25, 2018
AOTMiT is preparing an opinion on 32 active substances for 75+ patients
AOTMiT (Polish HTA Agency) is preparing an opinion on the appropriateness of including 32 active substances from 26 limit groups (full list here) ) for reimbursement list for patients over 75 years of age. 90% of drugs containing the mentioned active substances within the analyzed groups are available for patients with a lump sum payment (PLN 3.20).
| ATC | ||||||||
| Name of the substance | L | M | N | D | C | G | H | |
| Leuprorelinum Goserelinum Triptorelinum | Tizanidinum Allopurinolum Febuxostat Acidum zoledronicum | Clonazepamum Lamotriginum Olanzapinum Quetiapinum Risperidonum Flupentixolum Chlorprothixenum Clomipraminum Amitriptylinum | Calcipotriolum + Betamethasonum | Digoxinum Metildigoxinum Propafenonum Amiodaronum Furosemidum Nitrendipinum Verapamilum Diltiazemum | Oxybutyninum | Fludrocortisonum Betamethasoni dipropionas + Betamethasoni natrii phosphas Dexamethasonum Methylprednisolonum Methylprednisolonum + Lidocainum | ||
